Tirzepatide pen sizes: doses, strengths and how the KwikPen works

What are the six tirzepatide pen sizes available in the UK?

The Mounjaro KwikPen is available in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Each pen contains enough medicine for four once-weekly injections. At lower strengths, the concentration per dose is lower; at higher strengths it is greater. You can read more about how the Mounjaro pen sizes differ across all six strengths, including why the colour-coded label matters so much as the quickest way to confirm you are holding the right pen before you inject.

Treatment always begins at the 2.5 mg pen. That starting strength is there to let your digestive system adjust gradually; it is a tolerability step rather than the dose expected to drive significant weight loss. How the pen is designed and what each component does is worth understanding before your first injection, particularly if you are switching from a different device.

The full overview of Mounjaro covers the medicine's dual GIP and GLP-1 mechanism in more detail. For now, the practical point is that each strength is a distinct, separately dispensed pen, you cannot adjust the dose within a single pen.

Does the pen change size when the dose increases?

No. The KwikPen format is consistent across all six strengths. The needle gauge, the injection button, the needle cover and the general dimensions remain the same whether you are holding a 2.5 mg or a 15 mg pen. What changes is the concentration of tirzepatide in the cartridge inside.

This matters practically: if you have moved up a strength and are collecting a new pen, check the label carefully. A 5 mg pen and a 7.5 mg pen are physically indistinguishable at a glance. Confirming the printed dose before you inject is good habit at every stage, not just at the start of treatment.

Needle length and gauge are standardised for the KwikPen and are covered in detail on the tirzepatide needle size guide. If you are ever unsure whether your pen is the correct strength, contact your prescribing team before injecting. Safe disposal of used pens requires a suitable sharps container; a one-litre sharps bin is an easy addition to keep alongside your treatment.

How does the dose progression through pen sizes normally work?

The licensed schedule starts at 2.5 mg for the first four weeks. After that, the prescriber reviews how you have tolerated the starting dose and, if appropriate, moves you to the 5 mg pen for the following four weeks. Increases then continue in 2.5 mg steps (to 7.5 mg, then 10 mg, 12.5 mg and finally 15 mg) each step roughly four weeks apart, though the pace is adjusted by your prescriber based on tolerability and response.

Not everyone reaches 15 mg. Clinical trials reported an average body-weight reduction of around 20–21% at the highest dose over 72 weeks, as published in the SURMOUNT-1 trial in the New England Journal of Medicine, but meaningful results can occur at lower maintenance doses too. If side effects are significant at a given strength, the prescriber may delay the next increase or hold the current dose longer.

The most common side effects during titration are gastrointestinal: nausea, loose stools, reduced appetite and occasional reflux. These tend to be most noticeable in the first week or two after moving up a pen size, then settle. Full side-effect information is in the Mounjaro Summary of Product Characteristics on the eMC. Questions about timing a dose increase (including what to do if you have had an unsettled few weeks just before you were due to move up) are exactly the kind of thing to raise with your prescriber rather than decide solo.

If a dose increase is coming up around a holiday or bank holiday, it is worth ordering your next pen a few days earlier than usual so stock and delivery align with your schedule rather than your prescriber having to chase on a Thursday afternoon.

Does the pen size affect how you inject?

The injection technique itself stays the same across all six pen sizes. Clean the skin at your chosen site (abdomen, thigh or upper arm) and rotate the injection spot each week to reduce the chance of skin reactions at any one location. The step-by-step injection guide walks through the full process.

Storage requirements are also consistent: all pen sizes should be kept refrigerated at 2–8°C. If you need to carry a pen when travelling or keep it at room temperature briefly, refer to the Patient Information Leaflet for the exact permitted window, the SmPC is specific on this and the figure is not one to rely on memory for. Arriving at the injection site with a pen that has been out of the fridge for longer than permitted is avoidable with a little planning.

The Mounjaro injection page covers site selection, rotation patterns and what to do if you notice redness or discomfort after injecting. If you are considering what treatment might suit you, speaking to our prescribers is the straightforward next step, it is a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.